FI20050814A0 - Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi - Google Patents

Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi

Info

Publication number
FI20050814A0
FI20050814A0 FI20050814A FI20050814A FI20050814A0 FI 20050814 A0 FI20050814 A0 FI 20050814A0 FI 20050814 A FI20050814 A FI 20050814A FI 20050814 A FI20050814 A FI 20050814A FI 20050814 A0 FI20050814 A0 FI 20050814A0
Authority
FI
Finland
Prior art keywords
rheumatoid arthritis
type
observing
procedure
collagen
Prior art date
Application number
FI20050814A
Other languages
English (en)
Swedish (sv)
Inventor
Marja-Kaisa Koivula
Juha Risteli
Original Assignee
Procollagen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procollagen Oy filed Critical Procollagen Oy
Priority to FI20050814A priority Critical patent/FI20050814A0/fi
Publication of FI20050814A0 publication Critical patent/FI20050814A0/fi
Priority to JP2008525592A priority patent/JP2009505049A/ja
Priority to US11/990,227 priority patent/US20090325884A1/en
Priority to AT06778497T priority patent/ATE456050T1/de
Priority to EP06778497A priority patent/EP1946109B1/en
Priority to PCT/FI2006/000275 priority patent/WO2007017556A1/en
Priority to DE602006011934T priority patent/DE602006011934D1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Emergency Alarm Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measurement Of Radiation (AREA)
FI20050814A 2005-08-11 2005-08-11 Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi FI20050814A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20050814A FI20050814A0 (fi) 2005-08-11 2005-08-11 Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
JP2008525592A JP2009505049A (ja) 2005-08-11 2006-08-10 関節リウマチにおいて形成される自己抗体を検出するための方法
US11/990,227 US20090325884A1 (en) 2005-08-11 2006-08-10 Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis
AT06778497T ATE456050T1 (de) 2005-08-11 2006-08-10 Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern
EP06778497A EP1946109B1 (en) 2005-08-11 2006-08-10 Method for detecting autoantibodies formed in rheumatoid arthritis
PCT/FI2006/000275 WO2007017556A1 (en) 2005-08-11 2006-08-10 Method for detecting autoantibodies formed in rheumatoid arthritis
DE602006011934T DE602006011934D1 (de) 2005-08-11 2006-08-10 Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20050814A FI20050814A0 (fi) 2005-08-11 2005-08-11 Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi

Publications (1)

Publication Number Publication Date
FI20050814A0 true FI20050814A0 (fi) 2005-08-11

Family

ID=34896278

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20050814A FI20050814A0 (fi) 2005-08-11 2005-08-11 Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi

Country Status (7)

Country Link
US (1) US20090325884A1 (fi)
EP (1) EP1946109B1 (fi)
JP (1) JP2009505049A (fi)
AT (1) ATE456050T1 (fi)
DE (1) DE602006011934D1 (fi)
FI (1) FI20050814A0 (fi)
WO (1) WO2007017556A1 (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708585D0 (en) 2007-05-03 2007-06-13 Queen Mary & Westfield College Novel antibody and use in diagnosis and therapy of arthropathies
EP2058663A1 (en) * 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
EP3112379A1 (en) 2008-03-21 2017-01-04 Universiteit Hasselt Biomarkers for rheumatoid arthritis
EP2325195A1 (en) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Viral citrullinated peptides and uses thereof
EP2402368A1 (en) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histone citrullinated peptides and uses thereof
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CA2807942C (en) * 2010-08-10 2021-07-27 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP3412680B1 (en) 2011-04-05 2020-11-04 Curara AB Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment
EP2527841A1 (en) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Methods for the diagnosis of rheumatoid arthritis
GB201302036D0 (en) * 2013-02-05 2013-03-20 Queen Mary & Westfield College Diagnosis
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
MX2016010835A (es) 2014-02-21 2017-07-11 Anokion Sa Terapeuticos dirigidos a la glucosa.
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3638296A1 (en) 2017-06-16 2020-04-22 The University Of Chicago Compositions and methods for inducing immune tolerance
AU2019225251A1 (en) 2018-02-26 2020-10-15 AnTolRx, Inc. Tolerogenic liposomes and methods of use thereof
CN111868073B (zh) * 2019-05-31 2021-04-30 广州市雷德生物科技有限公司 一种类风湿关节炎相关的特异性多肽及其应用
CN110456074B (zh) * 2019-08-27 2022-06-03 广东菲鹏生物有限公司 瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒
WO2022202876A1 (ja) * 2021-03-24 2022-09-29 積水メディカル株式会社 Ｉ型コラーゲンｃ末端テロペプチドの免疫学的分析方法
CN113109574A (zh) * 2021-04-15 2021-07-13 北京森美希克玛生物科技有限公司 检测抗突变型瓜氨酸化波形蛋白抗体的试剂盒以及检测方法
CN113917135A (zh) * 2021-10-18 2022-01-11 北京和杰创新生物医学科技有限公司 抗角蛋白抗体的免疫球蛋白g的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3513915A1 (de) * 1985-04-17 1986-10-23 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Immunologischer testkit
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
EP1571450A3 (en) * 1999-06-17 2006-08-16 Washington Research Foundation Cartilage resorption assays
EP1435970A4 (en) * 2001-10-18 2005-05-04 Ilex Products Inc METHOD OF TREATING SKIN WITH DIPHOSPHONATE DERIVATIVES
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
DE60324393D1 (de) * 2002-02-12 2008-12-11 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
AU2003275294A1 (en) * 2002-09-30 2004-04-23 Shriners Hospital For Children Products for regulating the degradation of collagen and methodsfor indentifying same
CA2518187A1 (en) * 2003-03-07 2004-09-16 London Health Sciences Centre Reseach, Inc. Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
ITTO20030246A1 (it) * 2003-03-31 2004-10-01 Univ Pisa Nuovi peptidi sintetici citrullinati e loro usi.
EP1882946B1 (en) * 2003-12-23 2010-02-17 Roche Diagnostics GmbH Method of assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6
JP2006133177A (ja) * 2004-11-09 2006-05-25 Institute Of Physical & Chemical Research 関節リウマチの診断および治療におけるシトルリン化アンチトロンビン３の利用

Also Published As

Publication number Publication date
WO2007017556A1 (en) 2007-02-15
DE602006011934D1 (de) 2010-03-11
ATE456050T1 (de) 2010-02-15
EP1946109A1 (en) 2008-07-23
EP1946109B1 (en) 2010-01-20
US20090325884A1 (en) 2009-12-31
JP2009505049A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
FI20050814A0 (fi) Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
Wu et al. Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis
Tabolacci et al. The role of tissue transglutaminase in cancer cell initiation, survival and progression
CY1119743T1 (el) Στοχοθετημενοι συνδετικοι παραγοντες εναντι β7-η1
CY1116967T1 (el) Συνθεσεις και μεθοδοι για θεραπευτικη αγωγη και διαγνωση καρκινου
NO20043245L (no) Bindingsproteiner som biosensorer
CY1119405T1 (el) Ενωση για την αναστολη ενζυμων
CY1118120T1 (el) Συνθεσεις βασιζομενες σε πεδιο ινωδονεκτινης τυπου iii, μεθοδοι και χρησεις αυτων
CY1117759T1 (el) Ενα καινουργιο φαρμακευτικο παρασκευασμα για την προ-εκλαμψια
EP1855719A4 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME
Sphyris et al. Subversion of niche-signalling pathways in colorectal cancer: what makes and breaks the intestinal stem cell
MX2007007259A (es) Inhibidores de homodimerizacion de myd88.
BR112012022943A2 (pt) inibidores de syk de imidazopiridnas
NO20043259L (no) Bindingsproteiner som biosensorer
Kwon et al. Impact of posttranslational modification in pathogenesis of rheumatoid arthritis: focusing on citrullination, carbamylation, and acetylation
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CY1114735T1 (el) Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5
CY1122198T1 (el) Ιατρικο προϊον και θεραπεια
CY1112322T1 (el) Παραγωγα σπειρο(5.5)ενδεκανιου
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
NO20070440L (no) Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt
Paradzik et al. The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma
EA201291345A1 (ru) Цитруллинированные гистоновые пептиды и их применение
Huang et al. Janus-Inspired Core–Shell Structure Hydrogel Programmatically Releases Melatonin for Reconstruction of Postoperative Bone Tumor
CY1115255T1 (el) Χρηση αναστολεων αποακετυλασης ιστονων για την φροντιδα philadelphia-αρνητικων μυελοπολλαπλασιαστικων συνδρομων